# The REACT-ICD Trial

> **NCT02439424** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Hartford Hospital** · enrollment: 6 (actual)

## Conditions studied

- Atrial Tachyarrhythmia
- Atrial Fibrillation

## Interventions

- **DEVICE:** Reactive ATP

## Key facts

- **NCT ID:** NCT02439424
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-12
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2016-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02439424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02439424, "The REACT-ICD Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02439424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*